chr15-55430729-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_130810.4(DNAAF4):c.1204G>A(p.Val402Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_130810.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF4 | NM_130810.4 | c.1204G>A | p.Val402Ile | missense_variant | 10/10 | ENST00000321149.7 | NP_570722.2 | |
DNAAF4-CCPG1 | NR_037923.1 | n.1408+1768G>A | intron_variant, non_coding_transcript_variant | |||||
DNAAF4 | NM_001033559.3 | c.1098G>A | p.Leu366= | synonymous_variant | 9/9 | NP_001028731.1 | ||
DNAAF4 | NM_001033560.2 | c.1047+4176G>A | intron_variant | NP_001028732.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF4 | ENST00000321149.7 | c.1204G>A | p.Val402Ile | missense_variant | 10/10 | 1 | NM_130810.4 | ENSP00000323275 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251300Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135840
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461058Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726866
GnomAD4 genome AF: 0.000112 AC: 17AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74300
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 18, 2023 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 402 of the DNAAF4 protein (p.Val402Ile). This variant is present in population databases (rs200856356, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with DNAAF4-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DNAAF4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at